Our recently renovated 503A compounding facility is top-notch — and so is our team.
Pentec Health’s prescription-based 503A sterile compounding facility provides protein therapies to meet the nutritional needs of malnourished dialysis patients and medications for patients with implanted intrathecal pumps. It features two cleanroom complexes having separate HVAC units with environmental controls to minimize airborne contamination. The facility recently passed a U.S. Food and Drug Administration (FDA) inspection resulting in no observations and no issuance of a Form 483, further endorsing our commitment to our 503A operation and excellence.
